Cargando…
Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and serous tubal intraepithelial carcinoma (STIC), believed to...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771701/ https://www.ncbi.nlm.nih.gov/pubmed/33384952 http://dx.doi.org/10.3389/fonc.2020.523989 |
_version_ | 1783629724658958336 |
---|---|
author | Acland, Mitchell Arentz, Georgia Mussared, Max Whitehead, Fergus Hoffmann, Peter Klingler-Hoffmann, Manuela Oehler, Martin K. |
author_facet | Acland, Mitchell Arentz, Georgia Mussared, Max Whitehead, Fergus Hoffmann, Peter Klingler-Hoffmann, Manuela Oehler, Martin K. |
author_sort | Acland, Mitchell |
collection | PubMed |
description | Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and serous tubal intraepithelial carcinoma (STIC), believed to be the precursor lesion for HGSOC, can also be associated with intraabdominal spread. To provide insight into the etiology of these precancerous lesions and to explore the potential molecular mechanisms underlying their metastatic behavior, we performed a proteomic mass spectrometry analysis in a patient with synchronous EIC and STIC. Through histological and molecular identification of precancerous lesions followed by laser capture microdissection, we were able to identify over 450 proteins within the precancerous lesions and adjacent healthy tissue. The proteomic analysis of STIC and EIC showed remarkable overlap in the proteomic patterns, reflecting early neoplastic changes in proliferation, loss of polarity and attachment. Our proteomic analysis showed that both EIC and STIC, despite being regarded as premalignant lesions, have metastatic potential, which correlates with the common presentation of invasive serous gynecological malignancies at advanced stage. |
format | Online Article Text |
id | pubmed-7771701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77717012020-12-30 Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential Acland, Mitchell Arentz, Georgia Mussared, Max Whitehead, Fergus Hoffmann, Peter Klingler-Hoffmann, Manuela Oehler, Martin K. Front Oncol Oncology Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and serous tubal intraepithelial carcinoma (STIC), believed to be the precursor lesion for HGSOC, can also be associated with intraabdominal spread. To provide insight into the etiology of these precancerous lesions and to explore the potential molecular mechanisms underlying their metastatic behavior, we performed a proteomic mass spectrometry analysis in a patient with synchronous EIC and STIC. Through histological and molecular identification of precancerous lesions followed by laser capture microdissection, we were able to identify over 450 proteins within the precancerous lesions and adjacent healthy tissue. The proteomic analysis of STIC and EIC showed remarkable overlap in the proteomic patterns, reflecting early neoplastic changes in proliferation, loss of polarity and attachment. Our proteomic analysis showed that both EIC and STIC, despite being regarded as premalignant lesions, have metastatic potential, which correlates with the common presentation of invasive serous gynecological malignancies at advanced stage. Frontiers Media S.A. 2020-12-15 /pmc/articles/PMC7771701/ /pubmed/33384952 http://dx.doi.org/10.3389/fonc.2020.523989 Text en Copyright © 2020 Acland, Arentz, Mussared, Whitehead, Hoffmann, Klingler-Hoffmann and Oehler http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Acland, Mitchell Arentz, Georgia Mussared, Max Whitehead, Fergus Hoffmann, Peter Klingler-Hoffmann, Manuela Oehler, Martin K. Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential |
title | Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential |
title_full | Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential |
title_fullStr | Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential |
title_full_unstemmed | Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential |
title_short | Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential |
title_sort | proteomic analysis of pre-invasive serous lesions of the endometrium and fallopian tube reveals their metastatic potential |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771701/ https://www.ncbi.nlm.nih.gov/pubmed/33384952 http://dx.doi.org/10.3389/fonc.2020.523989 |
work_keys_str_mv | AT aclandmitchell proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential AT arentzgeorgia proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential AT mussaredmax proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential AT whiteheadfergus proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential AT hoffmannpeter proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential AT klinglerhoffmannmanuela proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential AT oehlermartink proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential |